| Determination of metabolic viability and cell mass using a tandem resazurin/sulforhodamine B assay FSG Silva, IG Starostina, VV Ivanova, AA Rizvanov, PJ Oliveira, ... Current protocols in toxicology 68 (1), 2.24. 1-2.24. 15, 2016 | 69 | 2016 |
| Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: Comparing with extracellular vesicles derived from mesenchymal stem cells MO Gomzikova, AM Aimaletdinov, OV Bondar, IG Starostina, ... Scientific Reports 10 (1), 10740, 2020 | 35 | 2020 |
| Дисферлинопатии: возможности диагностики, моделирования и генно-клеточной терапии АА Старостина, И. Г., Соловьева, В. В., Юрьева, К. С., Шевченко, К. Г ... Гены и клетки 8 (3), 62-70, 2013 | 7 | 2013 |
| Modeling and gene therapy of dysferlinopathy I Starostina, V Solovyeva, K Yuryeva, K Shevchenko, V Fedotov, ... SCOPUS1815445X-2013-8-3-SID84887112580, 2013 | 3 | 2013 |
| Formation of the recombinant adenovirus encoding codon-optimized dysferlin gene and analysis of the recombinant protein expression in cell culture in vitro IG Starostina, VV Solovyeva, KG Shevchenko, RV Deev, AA Isaev, ... Genes Cells 7, 25-28, 2012 | 2 | 2012 |
| Mutation correction in exons 3 and 26 of DYSF gene by artificial trans-splicing IA Yakovlev, RV Deev, AA Rizvanov, VV Solovyeva, IG Starostina, ... Human gene therapy 27 (S), 2016 | 1 | 2016 |
| Intranasal Administration of Microvesicles in the Brain of Mice with Induced Model of Alzheimer’s Type of Neurodegeneration D Zhdanova, M Gomzikova, N Bobkova, I Starostina, V Kovalev, ... BioNanoScience 12 (2), 685-692, 2022 | | 2022 |
| Mesenchymal stem cells derived microvesicles convey mesenchymal phenotype to recipient cells S Kurbangaleeva, S Kletukhina, I Starostina, A Rizvanov, M Gomzikova EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 50, 85-85, 2020 | | 2020 |
| MyoD-indutsirovannaya transdifferentsirovka dermal'nykh fibroblastov s mutatsiey v gene DYSF, rassmatrivaemaya kak test-sistema dlya skrininga preparatov disferlinopatii IG Starostina, DS Chulpanova, AA Shaymardanova, VV Solov'eva, ... Genes & Cells 14 (3), 220-221, 2019 | | 2019 |
| Primenenie CRISPR-oposredovannoy transkriptsionnoy aktivatsii s tsel'yu sozdaniya kletochnykh test-sistem dlya razrabotki i proverki metodov gennoy terapii nasledstvennykh … IA Yakovlev, IG Starostina, DS Chulpanova, AA Shaymardanova, ... Genes & Cells 14 (3), 270-270, 2019 | | 2019 |
| Modifikatsiya kletok HEK293A s ispol'zovaniem tekhnologii CRISPR-Cas9 SAM dlya transkriptsionnoy aktivatsii gena disferlina IG Starostina, AA Shaymardanova, DR Agliullina, VV Solov'eva, ... Genes & Cells 14 (3), 221-221, 2019 | | 2019 |
| Gene modification of HEK293A cells using CRISPR-Cas9 SAM technology for the transcriptional activation of dysferlin gene IG Starostina, AA Shaimardanova, DR Agliullina, VV Solovyeva, ... HUMAN GENE THERAPY 30 (11), A190-A190, 2019 | | 2019 |
| Assessment of exon-skipping feasibility for treatment of dysferlinopathy IA Iakovlev, RV Deev, DO Buev, VV Solovyeva, IG Starostina, ... HUMAN GENE THERAPY 30 (11), A166-A166, 2019 | | 2019 |
| Biosynthesis of DYSF protein in Bla/J dysferlin-deficient mice after administration of recombinant adenovirus encoding dysferlin cDNA IG Starostina, AA Shaimardanova, VV Solovyeva, AA Titova, ... HUMAN GENE THERAPY 29 (12), A138-A138, 2018 | | 2018 |
| Transcriptional activation of mutant dysferlin gene expression in human skin fibroblasts using CRISPR/Cas9 SAM technology AA Shaimardanova, IG Starostina, VV Solovyeva, DR Agliullina, ... HUMAN GENE THERAPY 29 (12), A142-A142, 2018 | | 2018 |
| Generation and Analysis of Genetically Modified CD14+ Monocytes with Dysferlin Overexpression I Starostina, V Soloveva, A Shaimardanova, R Deev, A Isaev, A Rizvanov Blood 130, 5565, 2017 | | 2017 |
| DNA and RNA editing of DYSF gene exon 26 for dysferlinopathy treatment IA Yakovlev, IG Starostina, AA Shaimardanova, VV Solovyeva, ... HUMAN GENE THERAPY 28 (12), A65-A65, 2017 | | 2017 |
| Generation and functional analysis in vitro of recombinant pCMV-DYSF plasmid encoding human DYSF gene IG Starostina, VV Solovyeva, AA Shaimardanova, RV Deev, AA Isaev, ... HUMAN GENE THERAPY 28 (12), A125-A125, 2017 | | 2017 |
| Effects of Ad5-DYSF transduction on skeletal muscles of dysferlin-deficient mice ON Chernova, AA Titova, MO Mavlikeev, IA Yakovlev, VV Solovyeva, ... HUMAN GENE THERAPY 28 (12), A43-A43, 2017 | | 2017 |
| Analiz vliyaniya ektopicheskoy ekspressii disferlina na proliferativnuyu aktivnost'kletok HEK293A posle elektroporatsii IG Starostina, VV Solov'eva, AA Shaymardanova, DR Agliullina, AA Isaev, ... Genes & Cells 12 (3), 232-233, 2017 | | 2017 |
